Regional demand for more equipment and sophisticated treatment is expected to grow.
Artificial intelligence is here to stay, but its ultimate success hinges on how it is deployed.
A look at where tech developments are originating and what to expect.
MRI-compatible pacemakers are among the technologies gaining traction.
Research and development activities to find potential treatments using next generation sequencing for various fatal conditions including melanoma, epilepsy, antibody deficiency, and other diseases have gained traction. In April, FDA finalized two guidance documents to speed up development of NGS-based tests.
The increase is significantly less than FY 2018, which saw user fees go up 33%.
The vote is a step towards getting rid of the tax for good.
Before accepting money, the following is a guide to your due diligence process.
The device will no longer be available after December 31, 2018.
Many considerations should not be overlooked.